Advisory: Alert from Equity-Insider.com was published in error and has been withdrawn
16/12/2025 17:43
An alert on cancer drug developers was inadvertently filed off a commentary by Equity-Insider.com and tagged to Immunome IMNM.O, Prelude Therapeutics PRLD.O, Context Therapeutics CNTX.O, Relay Therapeutics RLAY.O and Oncolytics ONCY.O. The alert has been withdrawn and there will be no substitute. STORY_NUMBER: nTUA1LWBBS STORY_DATE: 16/12/2025 STORY_TIME: 05:18:00 PM GMT ((bangalore.newsroom@thomsonreuters.com))
Recent news on Immunome
See all newsBrief: Immunome - Enters Amendment No. 4 To License Agreement With Bristol-Myers Squibb Company On Oct 2, 2026
US STOCKS ON THE MOVE-Cardinal Health, nVent, Acuity
U.S. STOCKS ON THE MOVE-Cardinal Health, Fervo Energy, Rocket Lab
U.S. STOCKS ON THE MOVE-Progress Software, Vicor Corp, Accenture
Immunome climbs as Stifel initiates coverage